Brigatinib: First Global Approval
Crossref DOI link: https://doi.org/10.1007/s40265-017-0776-3
Published Online: 2017-06-08
Published Print: 2017-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Markham, Anthony
License valid from 2017-06-08